Asthma Drugs Market in the US 2015-2019

www.technavio.comenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Asthma Drugs Market in the US 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Buying Criteria

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on the

Asthma Drugs Market in the US 2015-2019,please mail us at

enquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “Despite the constraints, the growing popularity of combination therapies for the treatment of individuals with asthma will fuel market growth. People with persistent asthma use these therapies to improve their quality of life. These therapies reduce asthma symptoms by controlling inflammation in the respiratory tract. Increased use of biologics to treat asthma is also likely to have a positive impact on market growth.”

• Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up.

• Technavio's analysts forecast the asthma drugs market in the US to grow at a CAGR of 4.64% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Asthma Drugs Market in the US 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and for a full list of vendors view our report:

Asthma Drugs Market in the US 2015-2019

AstraZeneca

F. Hoffmann-La Roche

GlaxoSmithKline

AstraZeneca plc is a global biopharmaceutical company and is involved in the discovery, development, and commercialization of medicines for various segments such as Cardiovascular and Metabolic Disease; Oncology; Respiratory, Inflammation, and Autoimmunity; and Infection, Neuroscience, and Gastrointestinal Disease.

Roche, a subsidiary of Roche Holding AG, is a healthcare company that undertakes discovery, development, manufacturing, and marketing of innovative diagnostic and therapeutic products and services.

GlaxoSmithKline was incorporated in 1999 as a result of the merger between Glaxo Wellcome and SmithKline Beecham. The company is headquartered in Brentford, Middlesex, UK. It develops, manufactures, and markets pharmaceutical products worldwide.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The introduction of pipeline products will cover up the declining market revenue caused by patent expiries of major drugs.

• This will result in steady market growth from 2018. Currently, drugs available in the market have a multiple-dose regimen.

• The launch of promising late-stage pipeline products, such as Benralizumab and Mepolizumab, will change the present market scenario.

• These drugs have a better safety and efficacy profile than the available drugs and also improve patient compliance.

USA – CANADA – UK – CHINA – INDIA

Key Buying CriteriaGuest Bloggers

• Authenticity • Delivery • Price• Service

Support

Parameter Details

Availability Drugs used to treat asthma should be readily available in the market.

Efficacy Drugs used to treat asthma should be efficient and show positive results.

Affordability Drugs used to treat asthma should be reasonably priced.

Safety Drugs used to treat asthma should be safe and have few or no side effects.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Asthma Drugs Market in the US 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

media@technavio.com

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION